Subscribe To
Pbyi or tech: which is the better value stock right now?
Investors with an interest in Medical - biomedical and Genetics stocks have likely encountered both Pum...
June 1, 2023, 12:50 pm
Lifecore biomedical reports third quarter fiscal year 2023 results
Going concern qualification is removed as a result of the $150 million new financing transaction announced last week CHASKA, Minn., June 01, 2023 (GLO...
June 1, 2023, 11:15 am
Clearside biomedical opens enrollment in odyssey phase 2b clinical trial of cls-ax (axitinib injectable suspension) in wet amd
– U.S. Clinical Sites Screening Treatment-Experienced Participants with Wet AMD – – ODYSSEY Topline Results Expected in Q3 2024 – ALPHARETTA, ...
June 1, 2023, 11:05 am
Ocean biomedical, inc. (nasdaq: ocea) announces addition to the russell 2000® index
Providence, RI, May 25, 2023 (GLOBE NEWSWIRE) — Ocean biomedical (NASDAQ: OCEA) announced today that ...
May 25, 2023, 12:01 pm
Lifecore biomedical: potential company sale
Lifecore biomedical jumped 50% yesterday after the company finally dispelled the previous going concern...
May 24, 2023, 6:07 pm
Why is ocean biomedical (ocea) stock up 28% today?
Ocean biomedical (NASDAQ: OCEA ) stock skyrocketed on Tuesday on the announcement of a potentially grou...
May 23, 2023, 4:31 pm
Dow jones newswires: lifecore biomedical stock climbs 19% on $150 million refinancing deal
Shares of Lifecore biomedical on Monday climbed 19% to $6.40 in after-hours trading after the company s...
May 23, 2023, 1:05 am
Lifecore biomedical stock climbs 19% on $150 million refinancing deal
Shares of Lifecore biomedical on Monday climbed 19% to $6.40 in after-hours trading after the company s...
May 22, 2023, 9:05 pm
Lifecore biomedical enters into $150.0 million in new financing, repays its outstanding term loans and signs new supply agreement to expand ha fermentation capacity with existing long-term customer
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan CHASKA, Minn., M...
May 22, 2023, 8:51 pm
Lifecore biomedical sets third quarter 2023 earnings conference call for june 1, 2023 at 7:30 a.m. ct
CHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract developm...
May 22, 2023, 8:49 pm
Lifecore biomedical sets third quarter 2023 earnings conference call for june 1, 2023 at 7:30 a.m. ct
CHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract developme...
May 22, 2023, 4:49 pm
Pbyi vs. tech: which stock is the better value option?
Investors looking for stocks in the Medical - biomedical and Genetics sector might want to consider eit...
May 16, 2023, 12:57 pm
Talis biomedical corporation (tlis) q1 2023 earnings call transcript
Talis biomedical Corporation (NASDAQ:TLIS ) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Co...
May 14, 2023, 10:58 am
Clearside biomedical announces first quarter 2023 financial results and provides corporate update
– Phase 2b ODYSSEY Trial of CLS-AX in Wet AMD Expected to Open Enrollment in Q2 2023 – – Positive Safety Data, Duration and Biologic Effect of C...
May 11, 2023, 11:05 am
Clearside biomedical, inc. (clsd) reports q1 loss, misses revenue estimates
Clearside Biomedical, Inc. (CLSD) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compa...
May 11, 2023, 9:56 am
Clearside biomedical to participate in a fireside chat at the jmp securities life sciences conference
ALPHARETTA, Ga., May 09, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery...
May 9, 2023, 8:30 pm
Wireless power transmission market to reach usd 28.6 billion at a cagr of 20.40% by 2030- report by market research future (mrfr)
Growing biomedical Applications Drive the Wireless Power Transmission Market Tokyo, Japan, May 08, 2023...
May 9, 2023, 12:00 am
Femasys’ femcerv endocervical tissue sampler for cervical cancer diagnosis receives product approval in canada
– FemCerv® is the first endocervical tissue sampler designed to collect and contain a comprehensive sample to maximize quality and quantity – ATL...
May 3, 2023, 12:30 pm
Clearside biomedical to report first quarter 2023 financial results and provide corporate update on thursday, may 11, 2023
ALPHARETTA, Ga., May 02, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery...
May 2, 2023, 7:05 am
The global marine biomedicine market was valued at usd 6.0 billion in 2022, is projected to grow at a cagr of 8.5% during the forecast period 2022 to 2030 | data by contrive datum insights pvt ltd.
According to a market research study published by Contrive Datum Insights, The study and application of marine life for medical objectives constitute ...
April 28, 2023, 1:20 pm